Lifshitz Law PLLC Announces Investigations of DSEY, KBAL, ADAP, and TCRR
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of DSEY to Solenis for $8.40 per share in cash.
NEW YORK, March 08, 2023 (GLOBE NEWSWIRE) --
Diversity Holdings, Ltd. (NASDAQ: DSEY)
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of DSEY to Solenis for $8.40 per share in cash.
If you are a DSEY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Kimball International, Inc. (NASDAQ: KBAL)
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of KBAL to HNI Corporation for $9.00 in cash and 0.3101 of HNI common stock for each share of Kimball common stock.
If you are an KBAL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
Adaptimmune Therapeutics PLC (NASDAQ: ADAP)
Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the merger of ADAP and TCR² Therapeutics, Inc. Following the merger, pre-merger Adaptimmune shareholders are expected to own approximately 75.0% of the outstanding equity of the combined company.
If you are an ADAP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
TCR² Therapeutics, Inc. (NASDAQ: TCRR)
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of TCRR and Adaptimmune Therapeutics PLC. Following the merger, pre-merger TCR² shareholders are expected to own approximately 25.0% of the outstanding equity of the combined company.
If you are an TCRR investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].
ATTORNEY ADVERTISING.© 2023 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: [email protected]
